¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ) Á¦ 54ȸ ´ëÇÑ°íÇ÷¾ÐÇÐȸ Ãá°èÇмú´ëȸ : 2021-05-21

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ) Á¦ 54ȸ ´ëÇÑ°íÇ÷¾ÐÇÐȸ Ãá°èÇмú´ëȸ : 2021-05-21
±³À°ÀÏÀÚ : 2021-05-21
±³À°Àå¼Ò : ¿Â¶óÀÎ ¿¬¼ö±³À°  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) Á¦ 54ȸ ´ëÇÑ°íÇ÷¾ÐÇÐȸ Ãá°èÇмú´ëȸ      
ÁÖÃÖ±â°ü : ´ëÇÑ°íÇ÷¾ÐÇÐȸ
´ã´çÀÚ : Á¤º°
¿¬¶ôó : 02-565-3350  
À̸ÞÀÏ : ksh@koreanhypertension.org      
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, ½Å°æ°ú, °¡Á¤ÀÇÇаú»ý¸®ÇÐ, ¾à¸®ÇÐ, ÀÇ·áÀ±¸®ÇÐ, ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ç, ÀÇÇб³À°
Âü¼®¿¹»óÀοø : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 18 ½Ã°£ 15ºÐ  
¼¼ºÎ¼ö°­·á : 30,000¿ø      
ºñ°í *µî·Ïºñ: »çÀüµî·Ï-±³¼ö ¹× °³¿øÀÇ 3¸¸¿ø / ÀüÀÓÀÇ, Àü°øÀÇ ±âŸ 1.5¸¸¿ø / 65¼¼ÀÌ»ó Á¤È¸¿ø, Çлý(¹«·á) *ÇöÀåµî·ÏÀº ¾øÀ½.      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-21 Rooom A 09:45~10:00 µ¿¸Æ°æÁ÷µµÀÇ °³³ä  Á¤Çý¹®(°æÈñÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom A 10:00~10:15 µ¿¸Æ°æÁ÷µµÀÇ ÃøÁ¤ ¹æ¹ý  ÃÖÀçÇõ(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom A 10:15~10:30 µ¿¸Æ°æÁ÷µµ¸¦ È°¿ëÇÑ ½É³úÇ÷°ü ÁúȯÀÇ Áø´Ü  ¹ÚÁø¼±(¾ÆÁÖÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom A 10:30~10:45 µ¿¸Æ°æÁ÷µµ¸¦ È°¿ëÇÑ ½É³úÇ÷°ü ÁúȯÀÇ ¿¹ÈÄ ¿¹Ãø  ±èÇзÉ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom B 09:45~10:00 ÀþÀº °íÇ÷¾Ð ȯÀÚ ÇöȲ: À¯º´·ü, ÀÎÁöÀ², Ä¡·áÀ², ÀþÀº °íÇ÷¾Ð ȯÀÚ ±ÞÁõÀÇ ¿øÀÎ, ÀÎÁöÀ² ¹× Ä¡·áÀ²ÀÌ ³·Àº ÀÌÀ¯  ±èÇý¹Ì(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom B 10:00~10:15 ÀþÀº °íÇ÷¾Ð ȯÀÚÀÇ Æ¯Â¡°ú ¹®Á¦Á¡: ÀþÀº °íÇ÷¾Ð ȯÀÚÀÇ ÀÓ»óÀû Ư¡, °íÇ÷¾Ð ÇÕº´Áõ ¹ß»ý·ü, Ç÷¾Ð Á¶ÀýÀ» ¼ÒȦÈ÷ ÇÏ¿´À» ¶§ÀÇ ¹®Á¦Á¡  Á¤¹ÌÇâ(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom B 10:15~10:30 ÀþÀº °íÇ÷¾Ð ȯÀÚÀÇ Ä¡·á ¹æ¹ý: »ýÈ°¿ä¹ý ¹× ¾à¹° Ä¡·á(¾î¶°ÇÑ ¾àÁ¦°¡ ¼±È£ µÇ´ÂÁö Æ÷ÇÔ)  Á¶µ¿Çõ(¿¬¼¼¿øÁÖÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom B 10:30~10:45 ÀþÀº °íÇ÷¾Ð ȯÀÚÀÇ ÀÎÁöÀ² ¹× Ä¡·áÀ²À» ³ôÀ̱â À§ÇÑ ¹æ¾È  ±èÇöÁø(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom C 09:45~10:00 ±¹³» Æó°íÇ÷¾Ð °ø´Ü ºòµ¥ÀÌÅÍ ºÐ¼®, 2004-2018  À念¿ì(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom C 10:00~10:15 Çѱ¹Çü Æó°íÇ÷¾Ð Áø·áÁöħ  ¹ÚÀçÇü(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom C 10:15~10:30 Æó°íÇ÷¾Ð Á¶ÀýÀ» À§ÇÑ »ýÈ° ½À°ü °ü¸®  ³ª½Â¿ø(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom C 10:30~10:45 Æó°íÇ÷¾Ð ȯÀÚ¿¡¼­ÀÇ ¿ÏÈ­ ÀÇ·á  ÀÌÁÖÈñ(ÃæºÏÀÇ´ë) 
Åä·Ð 05-21 Rooom C 10:45~11:00 Åä·Ð  ±è±â¹ü À̼ö¿ë ÀÌâÈÆ(¼­¿ïÀÇ´ë ºÎ»êÀÇ´ë ¿ø±¤ÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom A 11:10~11:25 Impact of COVID-19 on BP control  °ø¹Î±Ô(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom A 11:25~11:40 Impact of COVID-19 on hypertensive complications  ÀÌÂùÁÖ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom A 11:40~11:55 COVID-19 vaccination Basic concept  ±âÇö±Õ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom A 11:55~12:10 COVID-19 vaccination and cardiovasular complications  Á¶À翵(Àü³²ÀÇ´ë) 
Åä·Ð 05-21 Rooom A 12:10~12:25 Åä·Ð  ±è¼ºÇØ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom B 11:10~11:25 Comparison of domestic and oversea guidelines on hypertensive complication screening  À̼±±â(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom B 11:25~11:40 Dyslipidemia in Hypertension Why and How to deal ?  ¼ÕÁ¤¿ì(¿¬¼¼¿øÁÖÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom B 11:40~11:55 ECG abnormality Why and How to deal ?  ±è¹ü¼º(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom B 11:55~12:10 Abnoraml U/A : Why and How to deal ?  ÃÖÀÚ¿¬(°í·ÁÀÇ´ë) 
Åä·Ð 05-21 Rooom B 12:10~12:25 Åä·Ð  ±èÀÀÁÖ ½Å¹Ì½Â ÃÖ¼ºÈÆ ÇѼº¿ì(°í·ÁÀÇ´ë °¡ÃµÀÇ´ë ÇѸ²ÀÇ´ë ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom C 11:10~11:25 Association of Blood Pressure With the Progression of CKD  ÀÌÁö¿µ(Àû½ÊÀÚº´¿ø) 
±³À°½Ã°£ 05-21 Rooom C 11:25~11:40 Optimal blood pressure for patients with CKD  ÀÌÀ¯ºó(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom C 11:40~11:55 Ambulatory blood pressure monitoring guided antihypertensive treatment  ±èÀ±¹Ì(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom C 11:55~12:10 Cardiovascular or mortality risk of controlled hypertension and importance of physical activity, Heart 2021  ¹Ú¼¼ÈÆ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom A 12:35~13:25 Luncheon Symposium I  ½ÅÁøÈ£(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom B 12:35~13:25 Luncheon Symposium II  ±èÇзÉ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom C 12:35~13:25 Luncheon Symposium III  ¹Ú¼ºÇÏ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom A 13:35~13:50 ÄڷγªÆÒµ¥¹Í¿¡¼­ ½ÅüȰµ¿ ½ÇõÀÇ À§±â  ÀÌ¿Â(½ºÆ÷Ã÷Á¤Ã¥°úÇпø) 
±³À°½Ã°£ 05-21 Rooom A 13:50~14:05 ÄڷγªÆÒµ¥¹Í¿¡¼­ ½ÅüȰµ¿ ½Çõ±Ç°í¾È(¸¶½ºÅ© Âø¿ë½Ã ¿îµ¿ Æ÷ÇÔ)  ±è¿ëȯ(°­¸ª¿øÁÖ´ëÇб³) 
±³À°½Ã°£ 05-21 Rooom A 14:05~14:20 ´Ù¾çÇÑ È¨Æ®·¹ÀÌ´× ½Çõ¹æ¹ý  ÀÌÁø¼®(½ºÆ÷Ã÷Á¤Ã¥°úÇпø) 
±³À°½Ã°£ 05-21 Rooom A 14:20~14:35 µðÁöÅÐ Ä¡·á±â¼úÀ» È°¿ëÇÑ ¿îµ¿ ÁßÀç Àü·«  ¹ÚÇöÅÂ(µ¿¾Æ´ëÇб³) 
±³À°½Ã°£ 05-21 Rooom B 13:35~13:50 The importance of healthy diets in hypertensive patients  ½Åµ¿Çõ(°­³² ¸ÞÀÌÀúº´¿ø) 
±³À°½Ã°£ 05-21 Rooom B 13:50~14:05 Mineral supplements  Àü°æÇö(±¹¹Î°Ç°­º¸Çè Àϻ꺴¿ø) 
±³À°½Ã°£ 05-21 Rooom B 14:05~14:20 Vitamin supplements  ±è¹üÅÃ(¾ÆÁÖÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom B 14:20~14:35 Omega-3 fatty acid supplements  ±ÇÀ¯Áø(¿¬¼¼ÀÇ´ë) 
Åä·Ð 05-21 Rooom B 14:35~14:50 Åä·Ð  ±èº´±Ô ±èÈ¿Àº ÀÌÁÖ¹Ì(ÀÎÁ¦ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø À»ÁöÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom C 13:35~13:50 Blood pressure variability and CVD disease  ±èÇзÉ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom C 13:50~14:05 Glucose variability and CVD disease  Á¤ÂùÈñ(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom C 14:05~14:20 Wearable technology in CVD disease  Àü±âÇö(¸ÞµðÇ÷º½º ¼¼Á¾º´¿ø) 
Åä·Ð 05-21 Rooom C 14:20~14:35 Åä·Ð  ±è°æ¼ö ¼­¿ø¿ì ¼­Àçºó È«ÁØÈ­(Â÷ÀÇ´ë ÇѸ²ÀÇ´ë ¼­¿ïÀÇ´ë À»ÁöÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom A 15:00~15:15 Coenzyme Q10  ¹Ú»ó¹Î(À»ÁöÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom A 15:15~15:30 Arginine  ±èÀÎö(°è¸íÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom A 15:30~15:45 ³ë´Ï, ºñÆ® ÁÖ½º  ½ÅÁ¤ÈÆ(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom A 15:45~16:00 Herbal medication: ¾çÆÄÁóÀ̳ª ²®Áú´Ù¸°¹°, ¹Îµé·¹Á󡦠 ÀÌÁÖÈñ(ÃæºÏÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom B 15:00~15:15 Familial associations of blood pressure and BMI  Àå¼­À±(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom B 15:15~15:30 Secular trends of blood pressure and BMI and their associations in children and adolescents  ±èÅÂÁ¤(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom B 15:30~15:45 Environmental exposure and drug induced hypertension in in children and adolescents  ½ÅÀçÀÏ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom B 15:45~16:00 Prematurity and hypertension  °ûÁöÈñ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom C 15:00~15:15 The impact of intensive blood pressure control for cognitive function  ÀÓ»óÇö(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom C 15:15~15:30 The impact of intensive blood pressure control for small vessel disease  ±èÁÖÇÑ(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom C 15:30~15:45 The blood pressure control strategy for the stroke survivors (ÀÓ»ó Áø·á Àû¿ë)  Á¤¿íÁø(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom C 15:45~16:00 The blood pressure control strategy for the patients with Parkinsonism (ÀÓ»ó Áø·á Àû¿ë)  Á¶ÀºÁÖ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom A 16:25~16:40 Aminopeptidase A inhibitor  ±èÇüÀ±(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom A 16:40~16:55 SGLT2 for treatment of hypertension  À̼ö¿ë(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom A 16:55~17:05 ARNI for treatment of hypertension  ÃÖÈ«¹Ì(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom A 17:05~17:20 Orlistat for treatment of obesity and hypertension  ¼ÕÀå¿ø(°¡Å縯ÀÇ´ë) 
Åä·Ð 05-21 Rooom A 17:20~17:35 Åä·Ð  Á¶Á¤¼±(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom B 16:25~16:40 Cardiovascular risk of isolated systolic or diastolic hypertension in young adults  ÀÌÈ£±Ô(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom B 16:40~16:55 Factors associated with hypertension management in young adults  Àü¿ë¿ì(´ëÇÑ»ê¾÷º¸°ÇÇùȸ) 
±³À°½Ã°£ 05-21 Rooom B 16:55~17:05 Age and sex specifc target of blood pressure for CVD prevention  ±èÇü·¡(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom C 16:25~16:40 Korean Hypertension Cohort ¼Ò°³  ÀÌÇØ¿µ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-21 Rooom C 16:40~16:55 °íÇ÷¾Ð ¿¬±¸¿¡¼­ °øÀÍÀû ºòµ¥ÀÌÅÍÀÇ Çʿ伺  ÀÌÁÖ¿¬(¼­¿ï´ëÇб³ ¾àÇдëÇÐ) 
±³À°½Ã°£ 05-21 Rooom C 16:55~17:05 À¯°ü±â°ü °øµ¿¿¬±¸½ÉÀÇÀ§¿øȸ ±¸¼º Á¦¾È  ±è±¤ÀÏ(¼­¿ïÀÇ´ë) 
Åä·Ð 05-21 Rooom C 17:05~17:20 Åä·Ð  ±èµ¿¿í ¹éÁø°æ ÀÌÀåÈÆ(±¹¹Î°Ç°­º¸Çè°ø´Ü NECA °æºÏÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (¿Â¶óÀÎ) Á¦ 54ȸ ´ëÇÑ°íÇ÷¾ÐÇÐȸ Ãá°èÇмú´ëȸ : 2021-05-21""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) ´ëÇÑÀ̺ñÀÎÈÄ°úÇÐȸ Á¦5ȸ ¹Ì·¡Æ÷·³ ¾È³» : 2021-05-22
´ÙÀ½±Û ¼¼ºê¶õ½ºº´¿ø (¿Â¶óÀÎ) 1Çбâ À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ(°³¿ø°¡¿¡¼­ ÀÇ·ÚµÈ Èï¹Ì·Î¿î ºñ°ú Áõ·Ê) : 2021-05-20
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21135 °æ±â Á¦10Â÷ ¿¬¼¼ÀÇ´ë ¼Ò¾Æû¼Ò³â°ú Áö¿ªÀÇ»ç Áý´ãȸ : 2024-07-31 0 52 2024-06-19
21134 °æ±â 2024 Çѱ¹¼ö¸éÇÐȸ ÇÏ°èÇмú´ëȸ : 2024-07-26 0 62 2024-06-19
21133 ¼­¿ï 2024³â ´ëÇÑÇǺη¹ÀÌÀúÇÐȸ Á¦25ȸ Çмú´ëȸ : 2024-07-21 0 44 2024-06-19
21132 ¼­¿ï ´ëÇÑÀÓ»ó¾Ï´ë»çÀÇÇÐȸ 2024³â Ãß°èÇмú´ëȸ IVC¿Í Detox : 2024-07-21 0 42 2024-06-19
21131 ´ë±¸ ´ë±¸°æºÏ³»°úÇÐȸ 2024³â Á¤±âÇмú´ëȸ : 2024-07-21 0 48 2024-06-19
21130 Á¦ÁÖ Á¦13ȸ ´ëÇѳ»ºÐºñÇÐȸ Á¦ÁÖÁöȸ ¿¬¼ö°­Á : 2024-07-20 0 24 2024-06-19
21129 ±¤ÁÖ Á¦225Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ ±¤ÁÖÀü³²Áöȸ ¿¬¼ö°­Á : 2024-07-16 0 24 2024-06-19
21128 ºÎ»ê ´ëÇѳ»°úÀÇ»çȸ Á¦3ȸ ÃÊÀ½ÆÄ ½ÇÀü ¾ÆÄ«µ¥¹Ì : 2024-07-15 0 60 2024-06-19
21127 ¼­¿ï 2024 ¼¼ºê¶õ½ºº´¿ø ¼ÒÈ­±âÇÐ ¿¬¼ö°­Á : 2024-07-14 0 51 2024-06-19
21126 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇÑôÃß¿µ»óÀÇÇÐȸ Á¤±â¿¬¼ö°­Á : 2024-07-14 0 34 2024-06-19
21125 ¼­¿ï Á¦29Â÷ Ưº°¿¬¼ö°­Á – »êºÎÀΰú Áúȯ óġÀÇ ÃֽŠÁö°ß : 2024-07-14 0 32 2024-06-19
21124 °­¿ø 2024³â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ °­¿øÁöȸ ¿¬¼ö°­Á : 2024-07-14 0 41 2024-06-19
21123 ¼­¿ï 2024³â ´ëÇѹ̼¼¼ö¼úÇÐȸ Ãá°è ¹Ì¼¼¼ö¼ú ¿öÅ©¼ó : 2024-07-14 0 40 2024-06-19
21122 ¼­¿ï Çѱ¹¹é³»Àå±¼Àý¼ö¼úÇÐȸ 2024 KSCRS Annual Symposium(2ÀÏÂ÷) : 2024-07-14 0 39 2024-06-19
21121 ¼­¿ï Á¦8ȸ ÀüÀÓÀÇ Àü°øÀÇ °³¿øÀǸ¦ À§ÇÑ °£Áúȯ ¿¬¼ö°­Á : 2024-07-14 0 61 2024-06-19
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷